HomeCancerColorectal

Colorectal

Colorectal

Adoptive switch of customized neoantigen-reactive TCR-transduced T cells in metastatic colorectal most cancers: section 2 trial interim outcomes

Editor -
Parkhurst, M. R. et al. Distinctive neoantigens come up from somatic mutations in sufferers with gastrointestinal cancers. Most cancers Discov. 9, 1022–1035 (2019).Article  ...
Colorectal

Rgenta Therapeutics’ RGT-61159 good points IND approval to deal with cancers

Editor -
Rgenta Therapeutics has secured approval for its investigational new drug (IND) utility for RGT-61159, an oral small molecule RNA modulator, to deal with...
Colorectal

Editorial: Advances in genetics and molecular prognosis in colorectal, abdomen, and pancreatic most cancers vol II

Editor -
Gastrointestinal (GI) cancers embody a variety of malignancies that have an effect on the digestive system. These cancers are among the many most...
Colorectal

Genome-wide polygenic threat scores for colorectal most cancers have implications for risk-based screening

Editor -
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. International most cancers statistics 2020: GLOBOCAN estimates of incidence...
Colorectal

Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal most cancers

Editor -
SufferersOf the 802 sufferers with RAS WT mCRC included within the PARADIGM efficacy evaluation inhabitants, 733 sufferers (91.4%) supplied knowledgeable consent for this...
1...353637...73Page 36 of 73

Hot Topics

Load more

Quick Links

Must Read

Popular Articles

© 2024 Cancer Care Portal. All rights reserved.